CVE-2020-10627 - CVE House
Back to Database
Status published High CVE-2020-10627

Insulet Omnipod Insulin Management System insulin pump product ID 19191...

Vulnerability Description

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2020-10627

Credits & Attribution

The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:

  • Thirdwayv Inc. reported this vulnerability to Insulet

References

Affected Vendor

Affected Software

Omnipod Insulin Management System
Vulnerable Versions:
19191, 40160, ZXP425, ZXR425

Timeline

Official Publish: December 1st, 2021
Last Modified: August 4th, 2024
Added to House: July 21st, 2026

CVSS Vectors

V3: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L

Weaknesses (CWE)

CWE-284

MITRE ATT&CK TTPs

T1190 Exploit Public-Facing Application
Initial Access
T1068 Exploitation for Privilege Escalation
Privilege Escalation
T1078 Valid Accounts
Persistence
T1213 Data from Information Repositories
Collection
T1565.002 Stored Data Manipulation
Impact